This brief report describes the provision of early pregnancy loss (EPL) management in New York State Federally Qualified Health Centers (FQHCs) and barriers to providing this care. Office-based early pregnancy loss (EPL) care is safe and suitable to FQHCs, yet the prevalence of provision in FQHCs is unknown. We found that few New York FQHCs…
This publication describes the provision of early pregnancy loss (EPL) management and factors that inhibit or enable providing this care among family physicians trained in early abortion during residency. EPL is a common experience. Treatment options include expectant management, medication, and uterine aspiration. Although family physicians can offer comprehensive EPL treatment in their office-based settings,…
This publication details an exploratory study of US primary care clinicians’ perspectives on the effects of mifepristone restrictions, including US Food and Drug Administration (FDA) regulations, on access to medication abortion and early pregnancy loss (EPL) management in primary care. Protocols including mifepristone are the most effective medication regimens for medication abortion and EPL management.…
For patients whose pregnancy was not seen on ultrasound, use this patient handout to help explain the next steps. You can also share our Ectopic Pregnancy Fact Sheet for more information on symptoms, tests, and treatment for ectopic pregnancy.
Most people ovulate 9-14 days after an abortion. Patients presenting to end a pregnancy may be interested in starting or changing their contraceptive method. Depending on a patient’s medical eligibility, the following contraceptive methods are safe and effective post-abortion: Estrogen/progestin pill, patch, ring Progestin-only pill, injection, implant, IUD Copper IUD Barrier methods Sterilization Fertility Awareness…
This website, developed by the Fenway Institute, contains an extensive library of learning modules, videos, webinars, and other resources to support health care organizations optimize quality, cost-effective, and dignified care for lesbian, gay, bisexual, transgender, queer, intersex, asexual, and all sexual and gender minority (LGBTQIA+) people. Link: https://www.lgbtqiahealtheducation.org/resources/
Some people who prefer birth control pills can’t use estrogen. Drospirenone is a new progestin-only pill (POP) that differs from the other available POP in some key ways. Until recently in the United States, the only available POP was norethindrone. Due to its short half-life, the norethindrone POP should be taken at nearly the same…
A Conversation About Contraception Zine follows a group of friends who attend a presentation on different birth control options held by their school’s health center. This evidence-based resource explains the many options of contraception that a person could consider.